Literature DB >> 2444892

Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants.

M J Francis1, G Z Hastings, A D Syred, B McGinn, F Brown, D J Rowlands.   

Abstract

Study of the immune response to synthetic antigens has shown that uncoupled peptides can realize their potential as vaccines only if they contain domains that react with helper T-cell receptors and Ia antigens in addition to antibody binding sites. Here we consider whether genetically restricted non-responsiveness to an uncoupled peptide could be overcome by synthesizing a peptide with an additional helper T-cell epitope from a different protein. We demonstrate that H-2d mice, which are non-responders to the 141-160 VP1 peptide of foot-and-mouth disease virus (FMDV), can be converted into responders by immunization with peptides containing the FMDV sequence with defined 'foreign' helper T-cell determinants from ovalbumin or sperm whale myoglobin. Furthermore, the virus-neutralizing activity of the antibody raised against peptide was dependent on the determinant used. Thus, FMDV peptides with the added sequences 323-339 from ovalbumin and 132-148 from sperm-whale myoglobin elicited a high degree of neutralizing activity in B10.D2 mice. The sera from mice which received the peptide with the added sequence 105-121 from sperm whale myoglobin did not neutralize the virus, although they had high levels of anti-141-160 FMDV peptide activity. Our data indicate that the T-cell help given by the 'foreign' epitopes is B-cell clone specific. These results are likely to have important implications for the design of peptide vaccines.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2444892     DOI: 10.1038/330168a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  36 in total

1.  Enhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopes.

Authors:  J T Roehrig; A J Johnson; A R Hunt; B J Beaty; J H Mathews
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

2.  Antibody responses to non-immunogenic synthetic peptides induced by co-immunization with immunogenic peptides.

Authors:  C D Partidos; O E Obeid; M W Steward
Journal:  Immunology       Date:  1992-10       Impact factor: 7.397

3.  Multiple B- and T-cell epitopes on a major allergen of Kentucky Bluegrass pollen.

Authors:  L Zhang; M Yang; P Chong; S S Mohapatra
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

4.  T-helper cell and associated antibody response to synthetic peptides of the E glycoprotein of Murray Valley encephalitis virus.

Authors:  J H Mathews; J E Allan; J T Roehrig; J R Brubaker; M F Uren; A R Hunt
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

5.  Ultrastructural localization of the putative precursors of the A4 amyloid protein associated with Alzheimer's disease.

Authors:  N Catteruccia; J Willingale-Theune; D Bunke; R Prior; C L Masters; A Crisanti; K Beyreuther
Journal:  Am J Pathol       Date:  1990-07       Impact factor: 4.307

6.  Liposome-entrapped T-cell peptide provides help for a co-entrapped B-cell peptide to overcome genetic restriction in mice and induce immunological memory.

Authors:  G Gregoriadis; Z Wang; Y Barenholz; M J Francis
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

7.  Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins.

Authors:  J Chinsangaram; C Beard; P W Mason; M K Zellner; G Ward; M J Grubman
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

8.  Foot-and-mouth disease virus can induce a specific and rapid CD4+ T-cell-independent neutralizing and isotype class-switched antibody response in naïve cattle.

Authors:  Nicholas Juleff; Miriam Windsor; Eric A Lefevre; Simon Gubbins; Pip Hamblin; Elizabeth Reid; Kerry McLaughlin; Peter C L Beverley; Ivan W Morrison; Bryan Charleston
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

9.  B- and T-lymphocyte responses to an immunodominant epitope of human immunodeficiency virus.

Authors:  R D Schrier; J W Gnann; A J Langlois; K Shriver; J A Nelson; M B Oldstone
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

10.  Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.

Authors:  M D Lairmore; A M DiGeorge; S F Conrad; A V Trevino; R B Lal; P T Kaumaya
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.